BASiBioanalytical Systems, Inc. |
|
We will advance health care through innovative science. Alliances, research services and unique products define our role in the worldwide effort to understand disease and develop therapeutic solutions.
Peter T. Kissinger, PhD
Chairman & CEO
pete@bioanalytical.com
Ronald E. Shoup, PhD
President & COO
Contract Research Operations
ron@bioanalytical.com
Candice B. Kissinger, MS
Sr. V P – Research
candice@bioanalytical.com
Michael R. Cox, CPA
V P – Finance, CFO & Treasurer
mcox@bioanalytical.com
Michael P. Silvon, PhD
V P – Corporate Planning & Development
silvon@bioanalytical.com
Craig S. Bruntlett, PhD
V P – Business Development
craig@bioanalytical.com
Gerry M. Henningsen, DVM, PhD, DABT, DABVT
Scientific Director - Toxicology
ghenningsen@bioanalytical.com
Michael S. Noone, BS
CRU General Manager
mnoone@bioanalytical.com
BASi was founded in 1974 as a specialized instrument company supporting academic scientists with a strong focus on neuroscience and analytical chemistry. Over the years, BASi became increasingly involved in biology, understanding how potential new drugs interact in mammalian species, from mice to humans. A variety of "-ologies" became a focus, including pharmacology, toxicology, psychology, pathology and cardiology. As outsourcing became a viable option for pharmaceutical companies, BASi became as much a service firm as a manufacturer. Today, 70% of sales are from contract research services and 30% from products. BASi has a unique partnership with Purdue University and is a preferred provider to several major pharmaceutical companies. The company has therapeutic area concentrations in central nervous system diseases, diabetes, antibiotics and antiviral compounds.
Currently BASi has a skilled staff of over 350 people, 80% of whom have science degrees and 50 with Ph.D. or DVM degrees. The company is headquartered in West Lafayette, Indiana and has laboratories in Mount Vernon, Indiana, McMinnville, Oregon, Baltimore, Maryland and in the United Kingdom.
BASi is a public company (BASI on Nasdaq) with an active acquisition program in the USA and Europe, and regularly explores licensing opportunities for new products.
LSRC, IPHRA, IMDMC, IMA, ISCC, IHIF, AALAS, GLPI, NAM, ALSSA